Heme oxygenase substrates acutely lower blood pressure in hypertensive rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 3 40-3, 1996, Pages

  Johnson, Robert A ^a   Lavesa, Manuel ^a   Deseyn, Katie ^a   Scholer, Matthew J ^a   Nasjletti, Alberto ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

heme L arginate; heme L lysinate; metalloporphyrin

Indexed keywords

BILIVERDIN; CARBON MONOXIDE; DEOXYCORTICOSTERONE; DEUTEROPORPHYRIN DERIVATIVE; HEME; HEME ARGINATE; HEME DERIVATIVE; HEME LYSINATE; HEME OXYGENASE; HEME OXYGENASE INHIBITOR; IRON; METALLOPORPHYRIN; PHENYLEPHRINE; UNCLASSIFIED DRUG; ZINC DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME MECHANISM; ENZYME SUBSTRATE; ESSENTIAL HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 33750684029     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.3.h1132     Document Type: Article

References (31)

1. Abraham, N. G., J. H.-C. Lin, M. L. Schwartzman, R. D. Levere, and S. Shibahara. The physiological significance of heme oxygenase. Int. J. Biochem. 20: 543-558, 1988.
2. Chernick, R. J., P. Martasek, R. D. Levere, R. Margreiter, and N. G. Abraham. Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology 10: 365-369, 1989.
3. Christodoulides, N., W. Durante, M. H. Kroll, and A. I. Schafer. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation 91: 2306-2309, 1995.
4. Graser, T., Y. P. Vedernikov, and D. S. Li. Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. Biomed. Biochim. Acta 49: 293-296, 1990.
5. Harrison, S. P., and I. M. Barlow. Three direct spectrophotometric methods for determination of total bilirubin in neonatal and adult serum, adapted to the Technicon RA-1000 analyzer. Clin. Chem. 35: 1980-1986, 1989.
6. Heistad, D. D., and R. C. Wheeler. Effect of carbon monoxide on reflexive vasoconstriction in man. J. Appl. Physiol. 32: 7-11, 1972.
7. Johnson, R. A., M. Lavesa, B. Askari, N. G. Abraham, and A. Nasjletti. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor role in rats. Hypertension Dallas 25: 166-169, 1995.
8. Kanten, W. E., D. G. Penny, K. Francisco, and J. E. Thill. Hemodynamic responses to acute carboxyhemoglobinemia in the rat. Am. J. Physiol. 244 (Heart Circ. Physiol. 13): H320-H327, 1983.
9. Levere, R. D., P. Martasek, B. Escalante, M. L. Schwartzman, and N. G. Abraham. Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. J. Clin. Invest. 86: 213-219, 1990.
10. Lindén, I.-B., O. Tokola, M. Karlsson, and R. Tenhunen. Fate of haem after parenteral administration of haem arginate to rabbits. J. Pharm. Pharmacol. 39: 96-102, 1987.
11. Liu, M., S. Okada, and T. Kawabata. Radical-promoting "free" iron level in the serum of rats treated with ferric nitrilotriacetate: comparison with two other iron chelate complexes. Acta Med. Okayama 45: 401-408, 1991.
12. Maines, M. D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 2: 2557-2568, 1988.
13. Marks, G. S., J. F. Brien, K. Nakatsu, and B. E. McLaughlin. Does carbon monoxide have a physiological function? Trends Pharmacol. Sci. 12: 185-188, 1991.
14. Martasek, P., M. L. Schwartzman, A. I. Goodman, K. B. Solangi, R. D. Levere, and N. G. Abraham. Hemin and L-arginine regulation of blood pressure in spontaneously hypertensive rats. J. Am. Soc. Nephrol. 2: 1078-1084, 1991.
15. Mehlhorn, R. J., and J. Gomez. Hydroxyl and alkoxyl radical production by oxidation products of metmyoglobin. Free Radical Res. Commun. 18: 29-41, 1993.
16. Mitrione, S. M., P. Villalon, J. D. Lutton, R. D. Levere, and N. G. Abraham. Inhibition of human adult and fetal heme oxygenase by new synthetic heme analogues. Am. J. Med. Sci. 296: 180-186, 1988.
17. Moncada, S., and E. A. Higgs. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21: 361-374, 1991.
18. Moore, M. R., K. E. L. McColl, C. Rimington, and A. Goldberg. Disorders of Porphyrin Metabolism. New York: Plenum, 1987, p. 21-44.
19. Penney, D. G., and R. M. Skikun. Hypertension is not exacerbated by chronic carbon monoxide exposure, with or without added salt, in the borderline hypertensive rat. Arch. Toxicol. Suppl. 14: 118-124, 1991.
20. Roman, R. J., M. L. Kaldunski, D. L. Mattson, M. Mistry, and A. Nasjletti. Influence of eicosanoids on renal function of DOCA-salt hypertensive rats. Hypertension Dallas 12: 287-294, 1988.
21. Sacerdoti, D., B. Escalante, N. G. Abraham, J. C. McGiff, R. D. Levere, and M. L. Schwartzman. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science Wash. DC 243: 388-390, 1989.
22. Schmidt, H. H. H. W. NO, CO and HO endogenous soluble guanylyl cyclase-activating factors. FEBS Lett. 307: 102-107, 1992.
23. Snedecor, G. W., and W. G. Cochran. Statistical Methods (7th ed.) Ames: Iowa State University Press, 1980, p. 215-237.
24. Stocker, R., A. F. McDonagh, A. N. Glazer, and B. N. Ames. Antioxidant activities of bile pigments: biliverdin and bilirubin. Methods Enzymol. 186: 301-311, 1990.
25. Stocker, R., Y. Yamamoto, A. F. McDonagh, A. N. Glazer, and B. N. Ames. Bilirubin is an antioxidant of possible physiological importance. Science Wash. DC 235: 1043-1046, 1987.
26. Suematsu, M., S. Kashiwagi, T. Sano, N. Goda, Y. Shinoda, and Y. Ishimura. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem. Biophys. Res. Commun. 205: 1333-1337, 1994.
27. Tenhunen, R., O. Tokola, and L-B. Lindén. Haem arginate, a new stable haem compound. J. Pharm. Pharmacol. 39: 780-786, 1987.
28. Vercellotti, G. M., and J. P. Tolins. Endothelial activation and the kidneys: vasomediator modulation and antioxidant strategies. Am. J. Kidney Dis. 21: 331-343, 1993.
29. Verma, A., D. J. Hirsch, C. E. Glatt, G. V. Ronnett, and S. H. Snyder. Carbon monoxide: a putative neural messenger. Science Wash. DC 259: 381-384, 1993.
30. Vreman, H. J., O. K. Lee, and D. K. Stevenson. In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG. Am. J. Med. Sci. 302: 335-341, 1991.
31. Waldman, S. A., and F. Murad. Biochemical mechanism underlying vascular smooth muscle relaxations: the guanylate cyclase-cyclic GMP system. J. Cardiovasc. Pharmacol. 12: S115-S118, 1988.